Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Non-White and Hispanic Patients Have Significantly Longer Time from Intent to CAR T Infusion (“Brain-to-Vein” Time) in Multiply Relapsed Diffuse Large B Cell Lymphoma

Neela Easwar, Anna Alperovich, Alexandra Gomez-Arteaga, Sebastian A. Mayer, Nora Chokr, Adrienne A. Phillips, Jingmei Hsu, Koen van Besien, Matthew Gromowsky, Matthew Lunning, Tsiporah B. Shore, Juliet N Barker, Samuel Yamshon

Blood (2024) 144 (Supplement 1): 2351.

https://doi.org/10.1182/blood-2024-201337

Published: 2024

Journal Articles

Observational Comparison of Overall Survival between Phase 1b Orca-T and Registry-Based Post-Transplant Cyclophosphamide Patients

Blood (2024) 144 (Supplement 1): 694.

https://doi.org/10.1182/blood-2024-205917

Published: 2024

Journal Articles

A Balancing Act: Outcomes of Post-Transplant Cyclophosphamide in Older Patients

Herman Van Besien, Samuel Yamshon, Alexandra Gomez-Arteaga, Nora Chokr, Sebastian A. Mayer, Michelle S Pasciolla, Rachel Abramova, Tsiporah B. Shore, Juliet N Barker, Anna Alperovich

Blood (2024) 144 (Supplement 1): 7375.

https://doi.org/10.1182/blood-2024-211361

Published: 2024

Journal Articles

Low Dose Total Body Irradiation Improves CD19 CAR-T Expansion, Persistence, and Trafficking, Leading to Enhanced Efficacy in Large B-Cell Lymphoma

Mohammad Alhomoud, Michelle Foley, Mayumi Sugita, Takahiro Yamazaki, Leandro Martinez, Samuel Yamshon, Alexandra Gomez-Arteaga, Paul Pagnini, Tsiporah B. Shore, Olivier Boyer, Renier Brentjens, Koen Van Besien, Lorenzo Galluzzi, Silvia Formenti, Jeremie Martinet, Monica L. Guzman

Blood (2023) 142 (Supplement 1): 1016.

https://doi.org/10.1182/blood-2023-185216

Published: 2023

Journal Articles

Clinical Factors but Not Somatic Mutations Predict for Survival in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Cell Transplant: Analysis of the North American Myelofibrosis Transplant Outcome (NAMTO) Study

Blood (2023) 142 (Supplement 1): 3181.

https://doi.org/10.1182/blood-2023-173441

Published: 2023

Journal Articles

Impact of Graft Source [Cord Blood Supported By CD34+ Selected Cells (Haplo-Cord) Vs. Matched Donor] on Transplant Outcomes in Myelofibrosis

Nima Ghalehsari, Zhengming Chen, Sebastian A. Mayer, Ghaith Abu-Zeinah, Tsiporah B. Shore, Ellen K. Ritchie, Richard T. Silver, Andrew I. Schafer, Joseph M. Scandura, Gail J. Roboz, Koen Van Besien, Alexandra Gomez-Arteaga

Blood (2023) 142 (Supplement 1): 6953.

https://doi.org/10.1182/blood-2023-185075

Published: 2023

Journal Articles

Epigenetic Priming with 5-Azacytidine Prior to Allogeneic Stem Cell Transplantation for Myeloid Malignancies with In Vivo T Cell Depletion: Results of a Phase II Trial

Mohammad Alhomoud, Usama Gergis, Adrienne A. Phillips, Jingmei Hsu, Zhengming Chen, Alexandra Gomez-Arteaga, Tsiporah B. Shore, Joseph Scandura, Koen Van Besien, Sebastian A. Mayer

Blood (2022) 140 (Supplement 1): 7583–7584.

https://doi.org/10.1182/blood-2022-170097

Published: 2022

Journal Articles

Molecular Landscape in Acute Myeloid Leukemia (AML) Patients (pts) from Mexico As an Initial Study to Identify Healthcare Disparities in Hispanic Populations: Alliance for Clinical Trials in Oncology [Alliance]

Nuria Mencia Trinchant, Jessica Kohlschmidt, Alexandra Gomez-Arteaga, John C. Byrd, Wendy Stock, Krzysztof Mrózek, Andrew J. Carroll, Richard M. Stone, Eileen Pacheco, Adolfo Martinez Tovar, Irma Olarte Carrillo, Anel Garcia Laguna, Christian Ramos Peñafiel, Duane C Hassane, Ann-Kathrin Eisfeld, Monica L. Guzman

Blood (2022) 140 (Supplement 1): 11009–11010.

https://doi.org/10.1182/blood-2022-170326

Published: 2022

Journal Articles

Screening Chest CT Prior to Allogenic Transplantation - High Rates of Occult Abnormalities

Mohammad Alhomoud, Alexandra Gomez-Arteaga, Sebastian A. Mayer, Jingmei Hsu, Adrienne A. Phillips, Tsiporah B. Shore, Koen van Besien

Blood (2021) 138 (Supplement 1): 1777.

https://doi.org/10.1182/blood-2021-153811

Published: 2021

Journal Articles

Impact of Peri-Transplant Molecular Mutations on Outcomes of AML Patients Undergoing Fludarabine/Melphalan Conditioned Allogeneic Stem Cell Transplant

Mateo Mejia Saldarriaga, Yassine Tahri, Sangmin Lee, Zhengming Chen, Tsiporah B. Shore, Danielle Guarneri, Sebastian A. Mayer, Adrienne A. Phillips, Alexandra Gomez-Arteaga, Pinkal Desai, Ellen Ritchie, Michael B. Samuel, Gail J. Roboz, Koen van Besien, Jingmei Hsu

Blood (2021) 138 (Supplement 1): 4833.

https://doi.org/10.1182/blood-2021-149297

Published: 2021

Journal Articles

Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF Administration

Nina Orfali, MB,PhD, Alexandra Gomez-Arteaga, MD, Danielle Guarneri, BS, CCRP, Jingmei Hsu, MD, Adrienne A. Phillips, MD MPH, Usama Gergis, MD MBA, Tsiporah B. Shore, MD, Sebastian A. Mayer, MD, Koen Van Besien, MD PhD

Blood (2019) 134 (Supplement_1): 2000.

https://doi.org/10.1182/blood-2019-129452

Published: 2019

Journal Articles

Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34 + progenitor Cells

Alexandra Gomez-Arteaga, MD, Nina Orfali, MB,PhD, Danielle Guarneri, BS, CCRP, Usama Gergis, MD MBA, Sebastian A. Mayer, MD, Jingmei Hsu, MD, Adrienne A. Phillips, MD MPH, Tsiporah B. Shore, MD, Koen Van Besien, MD PhD

Blood (2019) 134 (Supplement_1): 2040.

https://doi.org/10.1182/blood-2019-129584

Published: 2019

Journal Articles

Cord Blood Transplants Supported By Unrelated Donor CD34 Progenitor Cells

Alexandra Gomez-Arteaga, MD, Danielle Guarneri, CCRP, Usama Gergis, MD M.B.A, Jingmei Hsu, MD, Sebastian A. Mayer, MD, Adrienne A. Phillips, MD MPH, Tsiporah B. Shore, MD, Koen Van Besien, MD PhD

Blood (2018) 132 (Supplement 1): 4646.

https://doi.org/10.1182/blood-2018-99-115502

Published: 2018

Journal Articles

A Phase II Study of a Novel Conditioning Regimen of Bendamustine and Melphalan Followed By Autologous Stem Cell Transplant for Patients with Multiple Myeloma

Alexandra Gomez-Arteaga, MD, Tomer M Mark, MDMSc, Danielle Guarneri, Paul J Christos, Dr.P.H., M.S., Usama Gergis, MD, June Greenberg, RN, Jingmei Hsu, MD PhD, Sebastian A. Mayer, MD, Ruben Niesvizky, MD, Roger Pearse, MD PhD, Adrienne A. Phillips, MD MPH, Adriana C. Rossi, MDMSc, Morton Coleman, MD, Koen Van Besien, MD PhD, Tsiporah B. Shore, MD

Blood (2017) 130 (Supplement 1): 4546.

https://doi.org/10.1182/blood.V130.Suppl_1.4546.4546

Published: 2017

Journal Articles

Clinical Utility of Morphological Evaluation of Day 14 Bone Marrow Biopsies in Acute Myeloid Leukemia Patients Undergoing Standard Induction Chemotherapy: Time to Change Practice?

Yehuda E. Deutsch, MD, German Campuzano-Zuluaga, MD, Matthew P Salzberg, Alexandra Gomez Arteaga, MD, Justin M. Watts, MD, Jennifer R Chapman, MD, Offiong F Ikpatt, MD, Francisco Vega, MD PhD, Ronan T Swords, MD PhD FRCPI, FRCPath

Blood (2014) 124 (21): 1004.

https://doi.org/10.1182/blood.V124.21.1004.1004

Published: 2014

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Non-White and Hispanic Patients Have Significantly Longer Time from Intent to CAR T Infusion (“Brain-to-Vein” Time) in Multiply Relapsed Diffuse Large B Cell Lymphoma

Observational Comparison of Overall Survival between Phase 1b Orca-T and Registry-Based Post-Transplant Cyclophosphamide Patients

A Balancing Act: Outcomes of Post-Transplant Cyclophosphamide in Older Patients

Low Dose Total Body Irradiation Improves CD19 CAR-T Expansion, Persistence, and Trafficking, Leading to Enhanced Efficacy in Large B-Cell Lymphoma

Clinical Factors but Not Somatic Mutations Predict for Survival in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Cell Transplant: Analysis of the North American Myelofibrosis Transplant Outcome (NAMTO) Study

Impact of Graft Source [Cord Blood Supported By CD34+ Selected Cells (Haplo-Cord) Vs. Matched Donor] on Transplant Outcomes in Myelofibrosis

Epigenetic Priming with 5-Azacytidine Prior to Allogeneic Stem Cell Transplantation for Myeloid Malignancies with In Vivo T Cell Depletion: Results of a Phase II Trial

Molecular Landscape in Acute Myeloid Leukemia (AML) Patients (pts) from Mexico As an Initial Study to Identify Healthcare Disparities in Hispanic Populations: Alliance for Clinical Trials in Oncology [Alliance]

Screening Chest CT Prior to Allogenic Transplantation - High Rates of Occult Abnormalities

Impact of Peri-Transplant Molecular Mutations on Outcomes of AML Patients Undergoing Fludarabine/Melphalan Conditioned Allogeneic Stem Cell Transplant

Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF Administration

Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34 + progenitor Cells

Cord Blood Transplants Supported By Unrelated Donor CD34 Progenitor Cells

A Phase II Study of a Novel Conditioning Regimen of Bendamustine and Melphalan Followed By Autologous Stem Cell Transplant for Patients with Multiple Myeloma

Clinical Utility of Morphological Evaluation of Day 14 Bone Marrow Biopsies in Acute Myeloid Leukemia Patients Undergoing Standard Induction Chemotherapy: Time to Change Practice?

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only